- Home
- GTX vs NNNN Comparison
GTX vs NNNN Comparison
Compare GTX & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- NNNN
- Stock Information
- Founded
- GTX 2018
- NNNN 2021
- Country
- GTX Switzerland
- NNNN Germany
- Employees
- GTX N/A
- NNNN N/A
- Industry
- GTX Auto Parts:O.E.M.
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GTX Consumer Discretionary
- NNNN Health Care
- Exchange
- GTX Nasdaq
- NNNN Nasdaq
- Market Cap
- GTX 2.6B
- NNNN 2.2B
- IPO Year
- GTX N/A
- NNNN 2025
- Fundamental
- Price
- GTX $12.85
- NNNN $50.91
- Analyst Decision
- GTX Strong Buy
- NNNN
- Analyst Count
- GTX 1
- NNNN 0
- Target Price
- GTX $14.00
- NNNN N/A
- AVG Volume (30 Days)
- GTX 2.5M
- NNNN 117.4K
- Earning Date
- GTX 07-24-2025
- NNNN 01-01-0001
- Dividend Yield
- GTX 1.86%
- NNNN N/A
- EPS Growth
- GTX 42.92
- NNNN N/A
- EPS
- GTX 1.43
- NNNN 0.06
- Revenue
- GTX $3,461,000,000.00
- NNNN $8,185,146.00
- Revenue This Year
- GTX $2.10
- NNNN N/A
- Revenue Next Year
- GTX $0.23
- NNNN N/A
- P/E Ratio
- GTX $9.04
- NNNN $941.70
- Revenue Growth
- GTX N/A
- NNNN 21.95
- 52 Week Low
- GTX $7.02
- NNNN $5.18
- 52 Week High
- GTX $13.32
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- GTX 65.10
- NNNN N/A
- Support Level
- GTX $12.44
- NNNN N/A
- Resistance Level
- GTX $12.91
- NNNN N/A
- Average True Range (ATR)
- GTX 0.31
- NNNN 0.00
- MACD
- GTX -0.06
- NNNN 0.00
- Stochastic Oscillator
- GTX 53.95
- NNNN 0.00
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.